EX-99.77O RULE 10F-3

                    MORGAN STANLEY CHINA "A" SHARE FUND, INC.
                          ITEM 77(O) 10F-3 TRANSACTIONS
                        JULY 1, 2009 - DECEMBER 31, 2009

                                                                   AMOUNT OF     % OF     % OF
                                      OFFERING                       SHARES     OFFERING  FUNDS
    SECURITY      PURCHASE/  SIZE OF  PRICE OF    TOTAL AMOUNT     PURCHASED   PURCHASED  TOTAL
   PURCHASED     TRADE DATE OFFERING   SHARES     OF OFFERING       BY FUND     BY FUND  ASSETS       BROKERS        PURCHASED FROM
- ---------------- ---------- -------- --------- ---------------- -------------- --------- ------ ------------------- ----------------
  Sinopharm      09/16/09      --    HKD16.000       USD $1.1 b        360,800    12.44%  0.19%    UBS Investment   UBS Securities
  Group Co.                                                                                         Bank, Morgan
                                                                                                      Stanley,
                                                                                                   Deutsche Bank,
                                                                                                    Citi, CICC,
                                                                                                       China
                                                                                                   International
                                                                                                      Capital
                                                                                                    Corporation
                                                                                                  Hong Securities
                                                                                                    Limited, UBS
                                                                                                   AG, Hong Kong
                                                                                                   Branch, Morgan
                                                                                                    Stanley Asia
                                                                                                      Limited,
                                                                                                     Citigroup
                                                                                                   Global Markets
                                                                                                   Asia Limited,
                                                                                                   Deutsche Bank
                                                                                                   AG, Hong Kong
                                                                                                   Branch, BOCOM
                                                                                                   International
                                                                                                     Securities
                                                                                                   Limited, China
                                                                                                     Merchants
                                                                                                  Securities (HK)
                                                                                                   Co., Limited,
                                                                                                       Daiwa
                                                                                                  Securities SMBC
                                                                                                     Hong Kong
                                                                                                   Limited, First
                                                                                                      Shanghai
                                                                                                     Securities
                                                                                                      Limited,
                                                                                                      Kingsway
                                                                                                     Financial
                                                                                                   Services Group
                                                                                                      Limited,
                                                                                                   Shenyin Wanguo
                                                                                                   Capital (H.K.)
                                                                                                      Limited



      China      09/25/09      --    HKD 3.900        USD $824m      1,490,000    12.42%  0.14%    Morgan Stanley,  Credit Suisse HK
    Resources                                                                                       Credit Suisse
      Cement

    Wynn Macau   09/30/09      --    HKD10.080       USD $1.63b      3,743,200     22.14   0.96    Morgan Stanley,  UBS Securities
       Ltd.                                                                                        J.P. Morgan,
                                                                                                   UBS Investment
                                                                                                    Bank, BofA
                                                                                                   Merrill Lynch,
                                                                                                   Deutsche Bank,
                                                                                                   ABN-AMRO, BNP
                                                                                                   PARIBAS, CLSA,
                                                                                                   Guocco Capital
                                                                                                      Limited

      China      12/04/09      --    HKD 8.160   $2,142,860,000      3,903,000     0.18%  0.68%    Morgan Stanley,  UBS Securities
  Longyuan Power                                                                                  UBS Investment
                                                                                                       Bank



  China Pacific  12/17/09      --    HKD28.000     $861,300,000      2,918,000     0.33%  1.83%     UBS Investment  UBS Securities
    Insurance                                                                                       Bank, Credit
                                                                                                    Suisse, CICC,
                                                                                                    Goldman Sachs

EX-99.77B ACCT LTTR

               Report of Independent Registered Public Accounting
          Firm

To the Shareholders and Board of Directors of
Morgan Stanley China A Share Fund, Inc.

In  planning and performing our audit of the financial statements
of Morgan Stanley China A Share Fund, Inc. (the "Fund") as of and
for  the  year  ended December 31, 2009, in accordance  with  the
standards  of  the  Public  Company  Accounting  Oversight  Board
(United  States), we considered the Fund's internal control  over
financial   reporting,  including  controls   over   safeguarding
securities, as a basis for designing our auditing procedures  for
the purpose of expressing our opinion on the financial statements
and  to  comply with the requirements of Form N-SAR, but not  for
the  purpose of expressing an opinion on the effectiveness of the
Fund's internal control over financial reporting. Accordingly, we
express no such opinion.


The  management  of the Fund is responsible for establishing  and
maintaining effective internal control over financial  reporting.
In  fulfilling  this responsibility, estimates and  judgments  by
management  are  required  to assess the  expected  benefits  and
related  costs  of  controls.  A  Fund's  internal  control  over
financial  reporting is a process designed to provide  reasonable
assurance  regarding the reliability of financial  reporting  and
the preparation of financial statements for external purposes  in
accordance  with  generally  accepted  accounting  principles.  A
Fund's  internal control over financial reporting includes  those
policies  and  procedures that (1) pertain to the maintenance  of
records that, in reasonable detail, accurately and fairly reflect
the  transactions and dispositions of the assets of the Fund; (2)
provide  reasonable assurance that transactions are  recorded  as
necessary  to  permit  preparation  of  financial  statements  in
accordance  with  generally accepted accounting  principles,  and
that receipts and expenditures of the Fund are being made only in
accordance with authorizations of management and directors of the
Fund;  and  (3) provide reasonable assurance regarding prevention
or   timely  detection  of  unauthorized  acquisition,   use   or
disposition of a Fund's assets that could have a material  effect
on the financial statements.


Because  of  its  inherent  limitations,  internal  control  over
financial  reporting  may  not prevent or  detect  misstatements.
Also,  projections of any evaluation of effectiveness  to  future
periods  are  subject  to  the  risk  that  controls  may  become
inadequate  because of changes in conditions, or that the  degree
of compliance with the policies or procedures may deteriorate.


A  deficiency in internal control over financial reporting exists
when  the  design  or  operation of  a  control  does  not  allow
management or employees, in the normal course of performing their
assigned  functions,  to  prevent or detect  misstatements  on  a
timely  basis.  A  material  weakness  is  a  deficiency,  or   a
combination  of deficiencies, in internal control over  financial
reporting,  such  that there is a reasonable possibility  that  a
material  misstatement of the Fund's annual or interim  financial
statements will not be prevented or detected on a timely basis.


Our  consideration of the Fund's internal control over  financial
reporting  was  for the limited purpose described  in  the  first
paragraph and would not necessarily disclose all deficiencies  in
internal   control  that  might  be  material  weaknesses   under
standards  established by the Public Company Accounting Oversight
Board  (United States). However, we noted no deficiencies in  the
Fund's   internal  control  over  financial  reporting  and   its
operation, including controls over safeguarding securities,  that
we  consider  to be a material weakness as defined  above  as  of
December 31, 2009.

This  report is intended solely for the information  and  use  of
management and the Board of Directors of Morgan Stanley  China  A
Share  Fund, Inc. and the Securities and Exchange Commission  and
is not intended to be and should not be used by anyone other than
these specified parties.


                                        Ernst & Young LLP


Boston, Massachusetts
February 23, 2010